STAT
SEPTEMBER 10, 2023
Among people who are still paying attention to Covid-19 , there’s been a recent surge — not just in viral activity but in the concern once again being paid to Covid. Headlines announce that transmission is surging and hospitalizations for Covid are rising by alarming percentages. There’s debate in some places about whether or not to resume wearing masks.
PharmExec
SEPTEMBER 10, 2023
First-of-its-kind treatment offers hope in the fight against rare heart disease.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
SEPTEMBER 10, 2023
SAN DIEGO — Crinetics Pharmaceuticals announced on Sunday that its experimental drug for acromegaly, a rare and serious hormonal disorder, succeeded in a late-stage trial, bringing the San Diego biotech a step closer to applying for Food and Drug Administration approval — and entry into a crowded market with blockbuster therapies sold by pharma giants.
Med Ed 101
SEPTEMBER 10, 2023
The Enjoyable Way To Study For The PTCB Exam! Introducing our new PTCB Crossword Puzzle Book! Great gift for any pharmacy technician or aspiring pharmacy student! We are excited to release a brand new book for our pharmacy technician friends! This will be priced as cheap as Amazon will let me for a short period […] The post As Cheap As Amazon Will Let Me!
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
BioPharm
SEPTEMBER 10, 2023
The biopharmaceutical industry supply chain experiences many bottlenecks, some of which may impact the sourcing of biochemicals and raw materials necessary to fulfill manufacturing demands during late stages of drug development. Establishing a partnership with a raw materials supplier with expertise in sourcing can be beneficial in navigating any unexpected turbulence and mitigating more common issues.
The FDA Law Blog
SEPTEMBER 10, 2023
By Mark A. Tobolowsky — CDER, CBER, and the Oncology Center of Excellence recently published a final guidance document titled “ Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products ” as another part of its real-world evidence (“RWE”) Program. This finalized a draft guidance issued in December 2021, largely similar in substance.
Expert insights. Personalized for you.
145 
Let's personalize your content